Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study

BACKGROUND: Patients with cancer are a population at high risk of severe infection from SARS-CoV-2. Patients with cancer regularly attend specialised healthcare centres for management and treatment, where they are in contact with healthcare workers (HCWs). Numerous recommendations target both patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Ladoire, Sylvain, Rederstorff, Emilie, Goussot, Vincent, Parnalland, Sophie, Briot, Nathalie, Ballot, Elise, Truntzer, Caroline, Ayati, Siavoshe, Bengrine-Lefevre, Leila, Bremaud, Nathalie, Coudert, Bruno, Desmoulins, Isabelle, Favier, Laure, Fraisse, Cléa, Fumet, Jean-David, Hennequin, Audrey, Hervieu, Alice, Ilie, Silvia, Kaderbhai, Courèche, Lagrange, Aurélie, Martin, Nils, Mazilu, Irina, Mayeur, Didier, Palmier, Rémi, Simonet-Lamm, Anne-Laure, Vincent, Julie, Zanetta, Sylvie, Arnould, Laurent, Coutant, Charles, Bertaut, Aurélie, Ghiringhelli, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806022/
https://www.ncbi.nlm.nih.gov/pubmed/35189537
http://dx.doi.org/10.1016/j.ejca.2022.01.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806022/
https://www.ncbi.nlm.nih.gov/pubmed/35189537
http://dx.doi.org/10.1016/j.ejca.2022.01.005

Ejemplares similares